Triplet Therapeutics
Cambridge
About Triplet Therapeutics
Triplet is developing transformative therapies that treat repeat expansion disorders at their source.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $59.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2019)
- Website: triplettx.com
- Phone: 781.299.7830
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/triplet-therapeutics-35124 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.